Suppr超能文献

使用SWITCH进行多重单核苷酸多态性基因分型:水凝胶中具有解释性分支介导序列解码的序列特异性纳米颗粒

Multiplex SNP Genotyping Using SWITCH: Sequence-Specific Nanoparticle with Interpretative Toehold-Mediated Sequence Decoding in Hydrogel.

作者信息

Choi Woongsun, Park Eunhye, Bae Seojin, Choi Kyung-Hak, Han Sangeun, Son Kuk-Hui, Lee Do Young, Cho Il-Joo, Seong Hyejeong, Hwang Kyo Seon, Nam Jwa-Min, Choi Jungkyu, Lee Hyojin, Choi Nakwon

机构信息

Department of Chemical and Biological Engineering, Korea University, Seoul, 02841, Korea.

Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Korea.

出版信息

Small. 2022 Feb;18(8):e2105538. doi: 10.1002/smll.202105538. Epub 2021 Dec 19.

Abstract

Single nucleotide polymorphisms (SNPs) that can alter phenotypes of individuals play a pivotal role in disease development and, more importantly, responses to therapy. However, SNP genotyping has been challenging due to the similarity of SNP alleles and their low concentration in biological samples. Sequence-specific nanoparticle with interpretative toehold-mediated sequence decoding in hydrogel (SWITCH) for multiplex SNP genotyping is presented. The encoding with gold nanoparticle probes transduces each SNP target to ≈1000 invaders with prominently different sequences between wild and mutant types, featuring polymerase chain reaction (PCR)-free amplification. Subsequently, the toehold-mediated DNA replacement in hydrogel microparticles decodes the invaders via SNP-specific fluorescence signals. The 4-plex detection of the warfarin-associated SNP targets spiked in commercially validated human serum (S1-100ML, Merck) is successfully demonstrated with excellent specificity. This work is the first technology development presenting PCR-free, multiplex SNP genotyping with a single reporting fluorophore, to the best of knowledge.

摘要

能够改变个体表型的单核苷酸多态性(SNP)在疾病发展中起着关键作用,更重要的是,在对治疗的反应中也起着关键作用。然而,由于SNP等位基因的相似性及其在生物样品中的低浓度,SNP基因分型一直具有挑战性。本文介绍了一种用于多重SNP基因分型的序列特异性纳米颗粒,其在水凝胶中具有解释性的支点介导的序列解码(SWITCH)。用金纳米颗粒探针进行编码可将每个SNP靶标转化为约1000个入侵者,野生型和突变型之间的序列有明显差异,具有无需聚合酶链反应(PCR)扩增的特点。随后,水凝胶微粒中支点介导的DNA置换通过SNP特异性荧光信号对入侵者进行解码。在商业验证的人血清(S1-100ML,默克公司)中加标的华法林相关SNP靶标的四重检测成功得到证明,具有出色的特异性。据我们所知,这项工作是首次开发出的一种技术,能够实现无PCR、单报告荧光团的多重SNP基因分型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验